A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation

NCT06019507 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation

Interventions

BIOLOGICAL: TCD601
BIOLOGICAL: Cyclophosphamide
DRUG: TAC
DRUG: MMF
DRUG: Corticosteroids

Sponsor

ITB-Med LLC